Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-04-13 | DistIT AB | Stefan Charette | Chairman of the Board of Directors | Acquisition | 204 585 | 7 | SEK | 1 432 095 | 2023-04-11 |
| 2023-04-13 | DistIT AB | Stefan Charette | Chairman of the Board of Directors | Acquisition | 2 795 300 | 7 | SEK | 19 567 100 | 2023-04-11 |
| 2023-04-13 | DistIT AB | Stefan Maximilian Charette | Chairman of the Board of Directors | Acquisition | 13 628 | 7 | SEK | 95 396 | 2023-04-10 |
| 2023-04-14 | H & M Hennes & Mauritz AB | Karl-Johan Persson | Chairman of the Board of Directors | Acquisition | 1 000 000 | 151,021 | SEK | 151 020 800 | 2023-04-11 |
| 2023-04-14 | H & M Hennes & Mauritz AB | Karl-Johan Persson | Chairman of the Board of Directors | Acquisition | 750 000 | 151,494 | SEK | 113 620 125 | 2023-04-12 |
| 2023-04-13 | Dicot AB | Michael Lars Åke Gustav Zell | Member of the Board of Directors | Disposal | 1 000 000 | 0,01 | SEK | 10 000 | 2023-04-12 |
| 2023-04-13 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Acquisition | 4 280 | 1,78 | SEK | 7 618,4 | 2023-04-11 |
| 2023-04-13 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Exercise decrease | 3 000 | 0 | SEK | 0 | 2023-04-11 |
| 2023-04-13 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Acquisition | 11 420 | 1,78 | SEK | 20 327,6 | 2023-04-11 |
| 2023-04-13 | Stayble Therapeutics AB | Thomas Pålsson | Chief Financial Officer (CFO) | Exercise decrease | 8 000 | 0 | SEK | 0 | 2023-04-11 |
| 2023-04-14 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Subscription | 40 000 | 1,78 | SEK | 71 200 | 2023-04-11 |
| 2023-04-14 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 250 599 | 0 | SEK | 0 | 2023-04-11 |
| 2023-04-14 | Stayble Therapeutics AB | Andreas Gerward | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 28 000 | 0 | SEK | 0 | 2023-04-11 |
| 2023-04-13 | Vidhance AB | Andreas Lifvendahl | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 10 000 | 1,17 | SEK | 11 700 | 2023-04-12 |
| 2023-04-13 | Alzinova AB | Margareth Jorvid | Other senior executive | Exercise decrease | 4 000 | 2,17 | SEK | 8 680 | 2023-04-12 |
| 2023-04-14 | Alzinova AB | Per-Göran Gillberg | Member of the Board of Directors | Exercise decrease | 6 000 | 2,17 | SEK | 13 020 | 2023-04-12 |
| 2023-04-14 | Alzinova AB | Stefan Pierrou | Other senior executive | Exercise decrease | 5 900 | 2,17 | SEK | 12 803 | 2023-04-05 |
| 2023-04-14 | Alzinova AB | Karl Sebastian Hansson | Other senior executive | Exercise decrease | 17 000 | 2,17 | SEK | 36 890 | 2023-04-11 |
| 2023-04-13 | Besqab AB (publ) | Johan Vestring | Other member of the company's administrative, management or supervisory body | Disposal | 5 000 | 0,65 | SEK | 3 250 | 2023-04-12 |
| 2023-04-13 | Rightbridge Ventures Group AB | Abelco Investment Group AB | Chairman of the Board of Directors | Allotment | 4 883 857 | 0 | SEK | 0 | 2023-04-11 |